Anti-SOX9 antibody [EPR14335] (ab185230) is a rabbit monoclonal antibody detecting SOX9 in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
- Over 140 publications
View Alternative Names
Transcription factor SOX-9, SOX9
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SOX9 antibody [EPR14335] (AB185230)
Immunohistochemical analysis of formalin fixed paraffin embedded human colon labelling SOX9 with ab185230 at a concentration of 0.1µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
Anti-SOX9 antibody [EPR14335] ab185230 was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-SOX9 antibody [EPR14335] (AB185230)
Immunofluorescent analysis of SW480 cells (4% paraformaldehyd-fixed) labeling SOX9 with ab185230 at 1/250 dilution followed by Goat anti rabbit IgG (Alexa Fluor® 555) secondary at 1/200 dilution and counter-stained with DAPI (blue).
Alexa Fluor® 488 (ab196450) and Alexa Fluor® 647 (ab196184) conjugated versions are available for this clone.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-SOX9 antibody [EPR14335] (AB185230)
Intracellular flow cytometric analysis of PC3 cells (2% paraformaldehyde-fixed)labeling SOX9 with ab185230 at 1/190 dilution (red) or a rabbit IgG (negative) (green), followed by Goat anti rabbit IgG (FITC) secondary at 1/150 dilution.
Alexa Fluor®488 (ab196450) and Alexa Fluor®647 (ab196184) conjugated versions are available for this clone.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SOX9 antibody [EPR14335] (AB185230)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling SOX9 with ab185230 at 1/2000 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin. Heat mediated antigen retrieval was performed with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-SOX9 antibody [EPR14335] (AB185230)
ab185230 at 1/60 immunoprecipitating SOX9 in SW480 (human colorectal adenocarcinoma) whole cell lysate observed at 56 and 75 KDa (lanes 1 and 2).
The expression pattern observed is consistent with the literature (PMID : 10682837) with an additional off-target band at 46 kD.
Lane 1 (input) : SW480 whole cell lysate 10μg
Lane 2 (+) : SW480 whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab185230 in SW480 whole cell lysate
For western blotting, ab185230 (1/1000) was used as the primary antibody and VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10,000 dilution.
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-SOX9 antibody [EPR14335] (ab185230)
Predicted band size: 56 kDa
Observed band size: 56 kDa,75 kDa
false
Exposure time: 10s
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SOX9 antibody [EPR14335] (AB185230)
Immunohistochemical analysis of paraffin-embedded Mouse colon tissue labeling SOX9 with ab185230 at 1/2000 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin. Heat mediated antigen retrieval was performed with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SOX9 antibody [EPR14335] (AB185230)
Immunohistochemical analysis of paraffin-embedded Rat colon tissue labeling SOX9 with ab185230 at 1/2000 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin. Heat mediated antigen retrieval was performed with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SOX9 antibody [EPR14335] (AB185230)
Immunohistochemical analysis of paraffin-embedded Mouse colon tissue labeling SOX9 with ab185230 at 1/2000 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin.
Heat mediated antigen retrieval was performed with EDTA buffer pH 9 before commencing with IHC staining protocol.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SOX9 antibody [EPR14335] (AB185230)
Immunohistochemical analysis of paraffin-embedded Rat colon tissue labeling SOX9 with ab185230 at 1/2000 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin.
Heat mediated antigen retrieval was performed with EDTA buffer pH 9 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-SOX9 antibody [EPR14335] (AB185230)
Immunofluorescence staining of SOX9 using ab185230 in primary hippocampal mouse neurons/glia (obtained from Transnetyx Tissue by BrainBits LLC cat.no. C57EHP) DIV14. The cells were fixed with 4% formaldehyde (10 min) permeabilized with 0.1% TritonX-100 (in PBS) for 5 mins and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab185230 at 5 μg/ml, ab4674 (anti-GFAP) at 1/1000 dilution and ab104224 (anti-NeuN) at 1/1000 dilution. Cells were then incubated with ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution (shown in green) ab150176 Goat Anti-Chicken IgY H&L (Alexa Fluor® 594) preadsorbed (shown in red) and ab150119 Goat Anti-Mouse IgG H&L (Alexa Fluor® 647) (shown in purple) all secondary antibodies at 1/1000 dilution. Nuclear DNA was labelled with DAPI (shown in blue).
As expected most GFAP positive cells are also SOX9 positive while NeuN positive cells are SOX9 negative.
Images were acquired with the Perkin Elmer Operetta HCA and a maximum intensity projection of confocal sections is shown.
- WB
Lab
Western blot - Anti-SOX9 antibody [EPR14335] (AB185230)
Western blot : Anti-Sox9 antibody [EPR14335] (ab185230) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab185230 was shown to bind specifically to Sox9. A band was observed at 50-70 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in Sox9 CRISPR-Cas9 edited cell line. The band observed in the CRISPR-Cas9 edited lysate lane below 50-70 kDa is likely to represent a truncated form of Sox9. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and Sox9 CRISPR-Cas9 edited HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-SOX9 antibody [EPR14335] (ab185230) at 1/1000 dilution
Lane 1:
Wild-type HCT 116 cell lysate at 20 µg
Lane 2:
Sox9 CRISPR-Cas9 edited HCT 116 cell lysate at 20 µg
Lane 3:
SW480 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 50 kDa,70 kDa
false
- WB
Lab
Western blot - Anti-SOX9 antibody [EPR14335] (AB185230)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
SOX9 can be ubiquitinated or SUMOylated to higher molecular weight (PMID : 24155239, PMID : 16307912, PMID : 16554309, PMID : 32070068). Meanwhile, it has a truncated version as mini-Sox9 (PMID : 21297661,PMID : 27429045).
HeLa expresses very low level of SOX9 (PMID : 18296708, PMID : 18677406).
All lanes:
Western blot - Anti-SOX9 antibody [EPR14335] (ab185230) at 1/1000 dilution
Lane 1:
SW480 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 4:
Mouse colon tissue lysate at 20 µg
Lane 5:
Mouse P0 bone tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 42 kDa,56 kDa,75 kDa
false
Exposure time: 40s
- WB
CiteAb
Western blot - Anti-SOX9 antibody [EPR14335] (AB185230)
SOX9 western blot using anti-SOX9 antibody [EPR14335] ab185230. Publication image and figure legend from Liu, N., Fu, D., et al., 2020, Arthritis Res Ther, PubMed 32398124.
ab185230 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab185230 please see the product overview.
Effects of AA on chondrogenic marker expression of chondrocytes. The cells were treated with or without AA (5 μM) for 3 days. a Representative immunofluorescence images of ACAN (yellow), COL-II (green), and SOX9 (red). Nucleus was stained with DAPI (blue). b The RFU analysis of ACAN, COL-II, and SOX9. Unpaired t test; ns, not significant. c Relative mRNA expression of ACAN, COL2a1, and SOX9. Unpaired t test, *p < 0.05, **p < 0.01. d Representative western blot of ACAN, COL-II, and SOX9. GAPDH was served as a loading control. e Representative Alcian Blue staining of human OA chondrocytes. Each experiment was repeated three times
false
Related conjugates and formulations (5)
-
Anti-SOX9 antibody [EPR14335] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-SOX9 antibody [EPR14335]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-SOX9 antibody [EPR14335]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-SOX9 antibody [EPR14335]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-SOX9 antibody [EPR14335]
Reactivity data
Product details
Anti-SOX9 antibody [EPR14335] (ab185230) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, IP, WB in human, mouse, rat samples.
Anti-SOX9 antibody [EPR14335] (ab185230) has been cited over 142 times in peer reviewed journals and is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-SOX9 antibody [EPR14335] (ab185230) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-SOX9 antibody [EPR14335] (ab185230) has 8 independent reviews from customers.
Anti-SOX9 antibody [EPR14335] (ab185230) specifically detects SOX9 (UniProt ID: P48436; Molecular weight: 56kDa) and is sold in 100 µL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone EPR14335 - ab220812.
Antibody clone EPR14335 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 488, Alexa Fluor® 555, Alexa Fluor® 594 (ab196184, ab196450, ab202516, ab202517).
SOX9 is a pivotal transcription factor involved in chondrogenesis and the regulation of various developmental processes. The SOX9 molecular weight is approximately 56 kDa. Research indicates that SOX9 plays a significant role in organ fibrosis and is implicated in several cancers. Utilizing SOX9 as a biomarker can enhance the understanding of its role in disease progression and potential therapeutic targets.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (213)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:8136 PubMed40885711
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 15:125 PubMed40885967
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 13:1592594 PubMed40607212
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic translation 53:82-98 PubMed40547193
2025
Applications
Unspecified application
Species
Unspecified reactive species
Genes 16: PubMed40428395
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4396 PubMed40355462
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 50:344-363 PubMed40297641
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ Regenerative medicine 10:20 PubMed40263309
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutics 17: PubMed40142944
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:403 PubMed40140224
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com